11:28 AM EST - Field Trip Health Ltd. : Announces the launch of “KAP Co-op”, a program that enables eligible independent psychedelic therapists to provide ketamine-assisted psychotherapy (and, in the future, other legal, psychedelic-assisted therapies) at its Field Trip Health centers. Field Trip is also pleased to announce the launch of training programs designed to provide interested psychotherapists or other qualified mental health professionals and clinicians with access to best-in-class training on KAP. Field Trip Health Ltd.
shares T.FTRP are trading up $0.08 at $5.72.
